DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactStocks

Zydus Wellness up 8%, PVR Inox down 7%: Check out other Nifty 500 top movers - CNBC TV18

LinkedIn 50 min ago·7 Sept 2026, 5:50 am

Zydus Wellness shares surged by 8% in early trade, making it one of the top gainers in the Nifty 500 index. The sharp rise in the stock price indicates strong investor confidence in the company's recent performance or sector outlook.

This move is significant for investors as it highlights Zydus Wellness as a potential leader in the consumer health space. The stock's performance could attract attention from both retail and institutional investors looking for growth opportunities in the FMCG sector.

Investors should monitor the company's future announcements and sector trends to gauge if this momentum is sustainable. Keeping an eye on broader market conditions will also help in assessing the stock's long-term potential.